Krsnaa Diagnostics Board Approves Key Management & Director Changes

Krsnaa Diagnostics' Board of Directors, at its meeting on April 17, 2026, approved significant leadership and governance changes. Mr. Raju Venkatraman and Ms. Lilian Jessie Paul were appointed as Additional Independent Directors for two years, effective April 25, 2026. Mr. Chetan Desai was re-appointed as an Independent Director for a subsequent five-year term. Mr. Chandra Prakash Singh was appointed as Interim Chief Financial Officer from April 17, 2026. Ms. Pallavi Bhatevara ceased to be a Whole-time Director, and Mr. Rajiva Ranjan Verma and Ms. Chhaya Palrecha ceased to be Independent Directors, all due to tenure completion. The Board also reconstituted its Audit, Nomination & Remuneration, Corporate Social Responsibility, Stakeholders Relationship, and Risk Management Committees, effective April 25, 2026, reflecting the new board composition.